These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26388626)

  • 21. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
    Kanakry JA; Li H; Gellert LL; Lemas MV; Hsieh WS; Hong F; Tan KL; Gascoyne RD; Gordon LI; Fisher RI; Bartlett NL; Stiff P; Cheson BD; Advani R; Miller TP; Kahl BS; Horning SJ; Ambinder RF
    Blood; 2013 May; 121(18):3547-53. PubMed ID: 23386127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease.
    Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D
    J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating cell-free Epstein-Barr virus DNA levels in patients with EBV-associated lymphoid malignancies.
    Lei KI; Chan LY; Chan WY; Johnson PJ; Lo YM
    Ann N Y Acad Sci; 2001 Sep; 945():80-3. PubMed ID: 11708499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Epstein-Barr virus and genotyping based on EBNA2 protein in Mexican patients with hodgkin lymphoma: a comparative study in children and adults.
    Palma I; Sánchez AE; Jiménez-Hernández E; Alvarez-Rodríguez F; Nava-Frias M; Valencia-Mayoral P; Salinas-Lara C; Velazquez-Guadarrama N; Portilla-Aguilar J; Pena RY; Ramos-Salazar P; Contreras A; Alfaro A; Espinosa AM; Nájera N; Gutierrez G; Mejia-Arangure JM; Arellano-Galindo J
    Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):266-72. PubMed ID: 23276887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma.
    Hohaus S; Santangelo R; Giachelia M; Vannata B; Massini G; Cuccaro A; Martini M; Cesarini V; Cenci T; D'Alo F; Voso MT; Fadda G; Leone G; Larocca LM
    Clin Cancer Res; 2011 May; 17(9):2885-92. PubMed ID: 21478335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma.
    Jo SA; Hwang SH; Kim SY; Shin HJ; Chung JS; Sol MY; Chang CL; Lee EY
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e106-13. PubMed ID: 19522857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi.
    Montgomery ND; Randall C; Painschab M; Seguin R; Kaimila B; Kasonkanji E; Zuze T; Krysiak R; Sanders MK; Elliott A; Miller MB; Kampani C; Chimzimu F; Mulenga M; Damania B; Tomoka T; Fedoriw Y; Dittmer DP; Gopal S
    Cancer Med; 2020 Jan; 9(2):552-561. PubMed ID: 31782984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus recruits PDL1-positive cells at the microenvironment in pediatric Hodgkin lymphoma.
    Jimenez O; Colli S; Garcia Lombardi M; Preciado MV; De Matteo E; Chabay P
    Cancer Immunol Immunother; 2021 Jun; 70(6):1519-1526. PubMed ID: 33184699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients.
    Au WY; Pang A; Choy C; Chim CS; Kwong YL
    Blood; 2004 Jul; 104(1):243-9. PubMed ID: 15031209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.
    Westmoreland KD; Montgomery ND; Stanley CC; El-Mallawany NK; Wasswa P; van der Gronde T; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Kampani C; Liomba NG; Tomoka T; Dhungel BM; Sanders MK; Krysiak R; Kazembe P; Dittmer DP; Fedoriw Y; Gopal S
    Int J Cancer; 2017 Jun; 140(11):2509-2516. PubMed ID: 28268254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EBV DNA: a Hodgkin lymphoma biomarker?
    Meyer RM
    Blood; 2013 May; 121(18):3541-2. PubMed ID: 23640993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
    Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
    Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma.
    Levin LI; Chang ET; Ambinder RF; Lennette ET; Rubertone MV; Mann RB; Borowitz M; Weir EG; Abbondanzo SL; Mueller NE
    Blood; 2012 Nov; 120(18):3750-5. PubMed ID: 22972983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.
    Barros MH; Vera-Lozada G; Soares FA; Niedobitek G; Hassan R
    Int J Cancer; 2012 Sep; 131(5):1142-52. PubMed ID: 22025264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.
    Lei KI; Chan LY; Chan WY; Johnson PJ; Lo YM
    Clin Cancer Res; 2002 Jan; 8(1):29-34. PubMed ID: 11801537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.
    Bienemann K; Borkhardt A; Klapper W; Oschlies I
    Histopathology; 2015 Nov; 67(5):607-16. PubMed ID: 25728094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of frequency of epstein-barr virus in non- Hodgkin lymphomas Using EBV latent membrane protein 1 (EBV-LMP1) immunohistochemical staining.
    Ishtiaq S; Hassan U; Mushtaq S; Akhtar N
    Asian Pac J Cancer Prev; 2013; 14(6):3963-7. PubMed ID: 23886215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation.
    Ruf S; Behnke-Hall K; Gruhn B; Bauer J; Horn M; Beck J; Reiter A; Wagner HJ
    J Clin Virol; 2012 Mar; 53(3):186-94. PubMed ID: 22182950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.